Literature DB >> 25233823

Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy.

A Goktas1.   

Abstract

PURPOSE: To evaluate the correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy (CSC).
METHODS: Twenty patients with acute unilateral treatment-naive idiopathic CSC and 20 age-matched normal eyes were included in this prospective cross-sectional study. Subretinal fluid volume (SRFV) of study eyes was estimated using a built-in segmentation-modifying tool of Spectralis spectral-domain optic coherence tomography (SD-OCT). Subfoveal choroidal thickness (SCT) (measured with enhanced depth imaging-OCT) and macular volume (MV) were also determined. The correlation of SRFV with SCT and MV was analyzed statistically.
RESULTS: There was no significant correlation of SRFV with SCT and MV in the study eyes (r=0.062, P=0.796 and r= -0.061, P=0.798, respectively). The mean SCT of the study eyes, the fellow eyes and the control eyes were 461.4±101.4, 375.3±103.7, 287.6±62.5 μm, respectively (P<0.001). The mean modified MV (determined excluding SRF volume) of the study eyes, the macular volume of the fellow and the control eyes was 8.57±0.59 mm(3), 8.75±0.4 mm(3) and 8.73±0.38 mm(3), respectively (P>0.05).
CONCLUSIONS: The current study shows that subretinal fluid volume does not correlate with subfoveal choroidal thickness. This novel finding suggests that formation of subretinal fluid is not solely associated with choroidal vasculature in acute CSC.

Entities:  

Mesh:

Year:  2014        PMID: 25233823      PMCID: PMC4268459          DOI: 10.1038/eye.2014.219

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

1.  The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography.

Authors:  Sushma K Vance; Yutaka Imamura; K Bailey Freund
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

2.  Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography.

Authors:  Waheeda Rahman; Fred Kuanfu Chen; Jonathan Yeoh; Praveen Patel; Adnan Tufail; Lyndon Da Cruz
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-08       Impact factor: 4.799

Review 3.  Central serous chorioretinopathy: an update on pathogenesis and treatment.

Authors:  M Gemenetzi; G De Salvo; A J Lotery
Journal:  Eye (Lond)       Date:  2010-10-08       Impact factor: 3.775

4.  Enhanced depth imaging spectral-domain optical coherence tomography.

Authors:  Richard F Spaide; Hideki Koizumi; Maria C Pozzoni; Maria C Pozonni
Journal:  Am J Ophthalmol       Date:  2008-07-17       Impact factor: 5.258

5.  Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy.

Authors:  Hidetaka Matsumoto; Taku Sato; Shoji Kishi
Journal:  Am J Ophthalmol       Date:  2009-03-27       Impact factor: 5.258

6.  Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Akira Ojima; Masashi Ogasawara; Richard F Spaide
Journal:  Ophthalmology       Date:  2010-05-15       Impact factor: 12.079

7.  Foveal thickness can predict visual outcome in patients with persistent central serous chorioretinopathy.

Authors:  Minoru Furuta; Tomohiro Iida; Shoji Kishi
Journal:  Ophthalmologica       Date:  2008-10-13       Impact factor: 3.250

8.  Central serous chorioretinopathy and indocyanine green angiography.

Authors:  F C Piccolino; L Borgia
Journal:  Retina       Date:  1994       Impact factor: 4.256

9.  Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy.

Authors:  Yutaka Imamura; Takamitsu Fujiwara; Ron Margolis; Richard F Spaide
Journal:  Retina       Date:  2009 Nov-Dec       Impact factor: 4.256

10.  Three-dimensional configuration of subretinal fluid in central serous chorioretinopathy.

Authors:  Soh-Eun Ahn; Jaeryung Oh; Jong-Hyun Oh; In Kyung Oh; Seong-Woo Kim; Kuhl Huh
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-03       Impact factor: 4.799

View more
  6 in total

1.  Macular ganglion cell complex thickness in acute and chronic central serous chorioretinopathy.

Authors:  Gülizar Demirok; Fatih Kocamaz; Yasemin Topalak; Yeşim Altay; Ahmet Sengun
Journal:  Int Ophthalmol       Date:  2016-06-20       Impact factor: 2.031

2.  Multimodal retinal imaging in central serous chorioretinopathy treated with oral eplerenone or photodynamic therapy.

Authors:  A Rabiolo; I Zucchiatti; A Marchese; G Baldin; R Sacconi; D Montorio; M V Cicinelli; L Querques; F Bandello; G Querques
Journal:  Eye (Lond)       Date:  2017-12-21       Impact factor: 3.775

3.  Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis.

Authors:  Guohai Chen; Radouil Tzekov; Wensheng Li; Fangzheng Jiang; Sihong Mao; Yuhua Tong
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

Review 4.  Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds.

Authors:  Kenji Yamashiro; Yoshikatsu Hosoda; Masahiro Miyake; Sotaro Ooto; Akitaka Tsujikawa
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

5.  Changes in the Foveal Outer Nuclear Layer of Central Serous Chorioretinopathy Patients Over the Disease Course and Their Response to Photodynamic Therapy.

Authors:  Kaixin Deng; Yufei Gui; Yi Cai; Zhiqiao Liang; Xuan Shi; Yaoyao Sun; Mingwei Zhao
Journal:  Front Med (Lausanne)       Date:  2022-01-14

Review 6.  Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation.

Authors:  Mary Ho; Gabriel Li; Andrew Mak; Danny Ng; Lawrence Iu; Frank Lai
Journal:  J Ophthalmol       Date:  2021-07-24       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.